Incyte signs development deal that aims to widen uses for blockbuster drug Jakafi

Delaware Business Now

Jan 6, 2021

Incyte and Cellenkos, Inc., a privately held, clinical-stage biotech company, announced a development collaboration to investigate the combination of Incyte's blockbuster blood dis…